Publications by authors named "D Fernandez de Sevilla"

Tuberculosis (TB), caused by Mycobacterium tuberculosis, is one of the 10 leading killer diseases in the world. At least one-quarter of the population has been infected, and there are 1.3 million deaths annually.

View Article and Find Full Text PDF

The Coronavirus Disease 2019 (COVID-19) pandemic has transformed health systems worldwide. There is conflicting data regarding the degree of cardiovascular involvement following infection. A registry was designed to evaluate the prevalence of echocardiographic abnormalities in adults recovered from COVID-19.

View Article and Find Full Text PDF

Background: Pharmacological intervention with laxatives is the conventional treatment for functional constipation (FC). Data to support the dietary management of FC is lacking. This study compared the efficacy of two Comfort young child formulas (YCFs) with regards to the maintenance of healthy stooling parameters in toddlers with a history of constipation.

View Article and Find Full Text PDF

Background: The optimal treatment of symptomatic Morton's neuroma remains unclear; conservative methods are sometimes ineffective and neurectomy has significant rates of patient dissatisfaction. The aim of this study was to evaluate the outcome of minimally invasive distal metatarsal metaphyseal osteotomy (DMMO) and percutaneous release of the deep transverse metatarsal ligament (DTML) in patients with Morton's neuroma.

Methods: Between January 2018 and November 2019, 27 patients (29 feet) diagnosed with Morton's neuroma after clinical and radiological evaluation underwent DMMO and percutaneous DTML release.

View Article and Find Full Text PDF
Article Synopsis
  • Plantar fasciitis is a common heel pain condition, and this study aims to compare the effectiveness of a single hyaluronic acid (HA) injection and extracorporeal shockwave therapy (ESWT) for chronic cases.
  • The trial will include 80 patients divided into two groups: one receiving three sessions of ESWT and the other one HA injection, with outcomes measured at multiple intervals using various pain and function scales.
  • Data collection started in November 2020, with a completion goal in November 2022, and the study's results are expected to be published by March 2023.
View Article and Find Full Text PDF